Tarsadia Investments

Pagos is a company based in Wilmington, Delaware, founded in 2021. It specializes in developing a Software as a Service (SaaS) financial platform aimed at helping businesses enhance their payment processing efficiency. The platform offers tools to normalize, visualize, aggregate, and monitor payment data, which helps companies improve performance, increase sales, and reduce the overall cost of accepting payments. Additionally, Pagos provides an application programming interface (API) that enables merchant companies to optimize and manage their payments, fostering business growth and long-term customer relationships.

Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, specializing in the design and development of holographic projection systems and computation algorithms for head-up and head-mounted displays. Founded in 2009, the company focuses on light manipulation through phase-only holography, leveraging advanced holographic and laser-based technologies to deliver high-quality images. Envisics aims to transform automotive displays and enhance the in-car experience by partnering with leading automakers and tier-one suppliers. Its dynamic holography platform enables the creation of head-up display images that overlay information seamlessly onto the driver’s field of view, thereby improving safety and providing essential driving information without distraction.

Matterworks is a developer of an artificial intelligence platform focused on advancing the field of metabolomics within the life sciences. The company's technology enhances analytical capabilities, allowing scientific researchers to conduct faster and more comprehensive metabolomic screenings. By facilitating the discovery and engineering processes, Matterworks aims to accelerate scientific progress and support innovation in various biological applications.

Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Jüsto is an online grocery store chain that specializes in delivery-only services. It provides a broad selection of items including fruits, vegetables, meat products, beauty products, and household supplies directly to consumers' doorsteps. The company focuses on offering fresh and healthy food products at competitive prices through its user-friendly platform.

Kirilys is a biopharmaceutical company focused on developing precision oncology assets aimed at improving the quality of life for cancer patients. Currently in the preclinical stages, the firm is working on a drug that has shown promising potency, selectivity, and anti-tumor efficacy. This drug is designed to be administered orally, which may enhance its usability for clinicians. In addition to addressing various cancers, Kirilys is also dedicated to improving treatment options for patients with chronic kidney disease. Through its innovative approach, the company aims to contribute significantly to the field of oncology and patient care.

Chronus Health, Inc. is a medical technology company that specializes in developing a portable diagnostic device capable of delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in Mountain View, California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time diagnostic capabilities. This innovative system allows for the delivery of lab results within minutes, significantly enhancing the speed of diagnosis and improving patient outcomes by enabling timely and informed treatment decisions.

Petal Card, Inc. is a credit card company focused on providing financial access to individuals without traditional credit histories, such as students and immigrants. Founded in 2015 and based in New York, the company utilizes machine learning to analyze users' digital financial records, allowing for cash flow underwriting as an alternative to conventional credit scoring. This innovative approach enables Petal to offer higher credit limits and lower rates compared to competing credit cards. The company's flagship product, the Petal Visa, is designed to promote responsible spending and credit-building, accompanied by a user-friendly digital application for managing payments. Petal aims to make credit more honest, simple, and accessible, fostering a financial environment that encourages users to succeed.

AvantStay, Inc. is a hospitality company founded in 2016 and headquartered in Los Angeles, California. It specializes in providing rental homes for vacations, offering a curated experience tailored to guests' preferences. The company operates over 450 premier properties across more than 60 cities, focusing on a drive-to market approach. AvantStay utilizes a proprietary technology platform to enhance the booking process and streamline both in-field and remote management. This innovative approach allows guests to browse and book short-term rentals conveniently and affordably. In 2019, AvantStay became one of the initial partners of Homes & Villas by Marriott International, further expanding its reach and service offerings.

Konfio is a financial services platform based in Mexico City, founded in 2013, that caters to small and medium-sized enterprises (SMEs) and micro entrepreneurs. The company offers a range of financial solutions including corporate credit cards, working capital loans, online payment solutions, and life insurance products. Konfio's mission is to support the growth and productivity of SMEs in Mexico by providing convenient and affordable access to credit options. The platform uses proprietary algorithms that combine data and technology to assess creditworthiness, thereby serving customers who are often underserved by traditional banking institutions.

Bolttech is an international InsurTech company specializing in AI-driven point-of-sale insurance solutions. Its platform offers a wide range of insurance products including device protection, travel, motor, property, life, and digital insurance to consumers worldwide, with a significant presence in Asia. Bolttech's technology enables seamless connections between insurers, distributors, and customers, facilitating efficient buying and selling of insurance products.

Konfio is a financial services platform based in Mexico City, founded in 2013, that caters to small and medium-sized enterprises (SMEs) and micro entrepreneurs. The company offers a range of financial solutions including corporate credit cards, working capital loans, online payment solutions, and life insurance products. Konfio's mission is to support the growth and productivity of SMEs in Mexico by providing convenient and affordable access to credit options. The platform uses proprietary algorithms that combine data and technology to assess creditworthiness, thereby serving customers who are often underserved by traditional banking institutions.

Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil, Inc., founded in 2015 and based in San Francisco, California, specializes in improving patient access to essential medications through its innovative prescription management software. The company operates a specialty Rx distribution platform that automates medication refills according to prescription schedules, acting as an intermediary between patients, prescribers, manufacturers, and pharmacists. Phil also offers complimentary home delivery services for medications. Its technology-driven approach aims to remove barriers to medication access, ensuring seamless therapy initiation and adherence. By providing end-to-end visibility into the prescription life cycle, Phil helps maximize reimbursement for brands while enhancing patient outcomes and provider experiences.

Yieldstreet is a management platform that provides retail investors access to income-generating investment products. Founded in 2015, It gives individuals access to alternative investments that have traditionally been off-limits to the average investor. With over $2.5 billion invested across multiple asset classes, Yieldstreet is changing the way people generate passive income by lowering and removing the barriers that historically kept these lucrative opportunities far out of reach. In 2013, founders Milind Mehere and Michael Weisz were frustrated that many investment strategies were typically reserved only for institutions and the ultra-wealthy. Typically, the average investor was left to choose between the stock market and bonds with falling yields - with few options in between. Asset-based investments had longer hold periods and a higher barrier of entry, keeping them well out of reach of accredited investors — even more so for unaccredited investors. As a result, they decided to leverage the growing fintech disruption to give more people access to these previously restricted alternative investments. Milind’s background in building companies combined with Michael’s decade-plus experience in investing and fund management formed the core of Yieldstreet. Passion for their investors and employees as well as a willing embrace of innovation, has been part of Yieldstreet’s identity from the beginning. Each decision to leverage a new technology, or investment strategy, or originate a new deal is made to put investors first. That drive has propelled Yieldstreet across all 50 states, crossing $100M invested in less than eight quarters, with the $1B milestone coming only three years later. In 2019, Yieldstreet’s membership had grown to 100,000, and a savings account for members was launched. Yieldstreet, since its launch in 2015, has not deviated from its goal to change investing for the better, nor has it slowed down. Yieldstreet was ranked number 46 on the Inc. 5000 list of the fastest-growing companies and has been recognized by Built In as one of the Best Places to Work. Yieldstreet today delivers wealth generation options and alternative investments for more than 330,000 investors and has returned more than $1.3 billion in principal/interest. Many alternative investment platforms only focus on one asset class, such as real estate or art. Yieldstreet’s offerings, accessed through cash or a low-fee IRA, cover a wide range of asset classes — art, real estate, legal, corporates, consumer, and commercial, via single investments or funds. Yieldstreet also offers its members short-term notes on offerings with a hold period between 3 and 6 months, which generally boast higher interest rates than money markets and CDs. Yieldstreet is headquartered in New York and has offices in Brazil, Greece, and Malta. Michael Weisz serves as President and Milind Mehere serves as CEO. Together, they manage a team of more than 140 employees, all working toward Yieldstreet’s one goal: to change the way people invest for the better.

Phil, Inc., founded in 2015 and based in San Francisco, California, specializes in improving patient access to essential medications through its innovative prescription management software. The company operates a specialty Rx distribution platform that automates medication refills according to prescription schedules, acting as an intermediary between patients, prescribers, manufacturers, and pharmacists. Phil also offers complimentary home delivery services for medications. Its technology-driven approach aims to remove barriers to medication access, ensuring seamless therapy initiation and adherence. By providing end-to-end visibility into the prescription life cycle, Phil helps maximize reimbursement for brands while enhancing patient outcomes and provider experiences.

BYJU'S is a prominent global ed-tech company founded in India in 2011, dedicated to providing adaptive and engaging learning solutions to over 150 million students worldwide. The company aims to make high-quality education accessible to learners of all ages through its flagship product, BYJU's: The Learning App, and a diverse portfolio that includes brands such as Disney-BYJU's Early Learn, BYJU's FutureSchool, and WhiteHat Jr. BYJU'S employs personalized learning methodologies that cater to individual learning styles and paces, supported by a network of over 12,000 teachers. The platform utilizes original content, watch-and-learn videos, animations, and interactive simulations to create a contextual and practical learning experience. Additionally, BYJU'S has formed innovative partnerships with major companies like Disney and Google to enhance engagement. Headquartered in India, BYJU'S operates in more than 21 countries and offers programs in over 8 languages, further solidifying its position as a leader in the education technology sector.

Loft is a residential real estate transactional marketplace based in São Paulo, Brazil, founded in 2018 by experienced entrepreneurs. As Brazil's first platform of its kind, Loft facilitates the buying and selling of properties for individuals, brokers, and publicly listed REITs managed by the company. The platform offers a searchable database that allows users to find, browse, and evaluate properties based on customer feedback and reviews. By utilizing proprietary transaction data and an end-to-end digital workflow, Loft modernizes the homebuying experience in Brazil, integrating various adjacent services to enhance the overall process for buyers and sellers.

Igneo is a company focused on addressing the challenges of electronic waste (e-waste) through its innovative recycling services. By utilizing patented multi-hearth technology, Igneo transforms raw, low-grade e-waste into sustainable and high-quality metal concentrates, recovering up to 98% of the precious metal content. This process not only offers a cleaner and more efficient alternative to traditional mining and metal recycling but also mitigates harmful emissions commonly associated with conventional methods. Igneo's closed-loop model involves the collaboration of original equipment manufacturers (OEMs) and smelters, reinforcing its commitment to environmentally friendly practices and promoting a more sustainable approach to resource management.

Brightvine is a developer of a blockchain-powered platform that aims to transform structured finance by integrating decentralized finance (DeFi) with the global fixed-income market. The company focuses on digitizing financial assets, creating a compliant infrastructure for the tokenization of fixed-income products. This innovation allows Web3 investors to access new investment opportunities while offering institutions enhanced sources of liquidity. Brightvine's platform facilitates the faster, cheaper, and easier sale and financing of assets, thereby streamlining the financial process and expanding market accessibility.

Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Petal Card, Inc. is a credit card company focused on providing financial access to individuals without traditional credit histories, such as students and immigrants. Founded in 2015 and based in New York, the company utilizes machine learning to analyze users' digital financial records, allowing for cash flow underwriting as an alternative to conventional credit scoring. This innovative approach enables Petal to offer higher credit limits and lower rates compared to competing credit cards. The company's flagship product, the Petal Visa, is designed to promote responsible spending and credit-building, accompanied by a user-friendly digital application for managing payments. Petal aims to make credit more honest, simple, and accessible, fostering a financial environment that encourages users to succeed.

Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Phil, Inc., founded in 2015 and based in San Francisco, California, specializes in improving patient access to essential medications through its innovative prescription management software. The company operates a specialty Rx distribution platform that automates medication refills according to prescription schedules, acting as an intermediary between patients, prescribers, manufacturers, and pharmacists. Phil also offers complimentary home delivery services for medications. Its technology-driven approach aims to remove barriers to medication access, ensuring seamless therapy initiation and adherence. By providing end-to-end visibility into the prescription life cycle, Phil helps maximize reimbursement for brands while enhancing patient outcomes and provider experiences.

Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

TrueMotion, Inc. is a Boston-based company that develops a smartphone-based telematics platform for insurance companies, aimed at enhancing driving safety. Founded in 2012 and previously known as Censio, the company utilizes advanced signal processing, machine learning, and data science to analyze smartphone sensor data. This technology allows insurers to differentiate between safe and risky drivers, rewarding safe driving behaviors with discounts on premiums. By promoting safer driving practices, TrueMotion contributes to reducing the number of driving accidents and fostering safer roads for all motorists.

Overseas Network is a vast large network committed to giving insider info to travel experts for all traveller needs.

Metallica Commodities is a trading company focused on non-ferrous and ferrous metal-containing materials, emphasizing the recycling of printed circuit boards. The company is engaged in the trading of metals and minerals, as well as the development of mineral assets. Its mineral asset projects are located in several countries, including Guyana, Uganda, Tanzania, and the Democratic Republic of the Congo. Additionally, Metallica Commodities processes aggregates and dimension stones, contributing to its diverse portfolio in the metals and minerals sector. Notably, it operates the world's first industrial facility dedicated to the recycling of printed circuit boards, highlighting its commitment to innovation and sustainability within the industry.

Cue Health Inc. is a healthcare technology company based in San Diego, California, specializing in the development and manufacturing of diagnostic screening devices for home use. Founded in 2010, the company offers a connected diagnostic platform known as the Cue Health Monitoring System, which allows users to conduct self-serve tests that provide lab-quality results. This platform enables individuals to track key health indicators, including inflammation, vitamin D, fertility, influenza, and testosterone, through a user-friendly device that connects to a smartphone app. The Cue app not only displays test results but also integrates data on lifestyle factors such as activity and sleep, facilitating a comprehensive view of health at a molecular level. Additionally, Cue Health provides various services for healthcare professionals, including tools for managing patient test histories and telemedicine consultations. The company's innovative approach empowers consumers and healthcare providers alike to access critical health information easily and effectively.

Envisics Limited is an automotive technology company based in Milton Keynes, United Kingdom, specializing in the design and development of holographic projection systems and computation algorithms for head-up and head-mounted displays. Founded in 2009, the company focuses on light manipulation through phase-only holography, leveraging advanced holographic and laser-based technologies to deliver high-quality images. Envisics aims to transform automotive displays and enhance the in-car experience by partnering with leading automakers and tier-one suppliers. Its dynamic holography platform enables the creation of head-up display images that overlay information seamlessly onto the driver’s field of view, thereby improving safety and providing essential driving information without distraction.

Nvoicepay, Inc. is a fintech company that specializes in cloud-based accounts payable software solutions. Founded in 2009 and headquartered in Beaverton, Oregon, with an additional office in San Francisco, California, Nvoicepay offers payment automation software that enables clients to pay invoices electronically, optimizing payment processes. The company's services include a payment command center, supplier enablement, and both customer and supplier payment support, aimed at streamlining accounts payable operations. By facilitating electronic payments to the right suppliers, Nvoicepay helps organizations reduce costs, enhance efficiencies, and maximize financial benefits, such as card rebates. As of 2019, Nvoicepay operates as a subsidiary of FleetCor Technologies, Inc., continuing to focus on delivering strategic payment solutions tailored for complex enterprises.

Asana BioSciences, LLC is a clinical-stage biopharmaceutical company located in Bridgewater, New Jersey, specializing in the discovery and development of innovative targeted therapies. Operating as a subsidiary of Amneal Pharmaceuticals, the company focuses on addressing medical needs in the fields of inflammation, immunology, oncology, and pain management. Asana BioSciences engages in early-stage drug discovery and development, providing valuable research and development services to the healthcare industry. Its portfolio includes multiple drug candidates aimed at creating new treatment options for both physicians and patients, thereby enhancing the potential for successful commercialization of its products.

DAQRI LLC is a company based in Los Angeles, California, specializing in augmented reality (AR) solutions aimed at enhancing workplace efficiency and safety. Founded in 2007, DAQRI develops a range of products, including its flagship 4D Studio, a web-based authoring tool designed for creating and managing immersive 4D experiences. The company also offers professional-grade AR wearables, such as smart glasses and helmets, which integrate digital content with the physical environment to streamline communication and productivity. Additionally, DAQRI provides industrial applications for sectors such as aerospace, healthcare, manufacturing, and education, focusing on training, maintenance, and real-time quality assurance. Its offerings include tools for visualizing data in augmented reality, as well as enterprise software and hardware integration services. With a presence in major U.S. cities and a commitment to driving innovation, DAQRI aims to empower workforces across various industries by improving operational processes and effectiveness.

Kashiv BioSciences is a fully integrated biopharmaceutical company focused on the development and manufacturing of complex pharmaceuticals, including biosimilars and complex generics. With research and development facilities located in Piscataway, New Jersey; Chicago, Illinois; and Ahmedabad, India, the company boasts capabilities in mammalian and microbial cell line development, advanced analytical characterization, and commercial-scale manufacturing. Kashiv is committed to improving patient outcomes by creating enhanced versions of established medications and addressing unmet medical needs. Its product pipeline features biosimilar candidates such as KSHB002, an abatacept biosimilar that successfully met primary endpoints in a Phase I trial. Through its innovative approaches and technologies, Kashiv BioSciences aims to provide significant value to patients and healthcare providers.

Prolong Pharmaceuticals, LLC, established in 2002 and headquartered in South Plainfield, New Jersey, specializes in developing biopharmaceutical products for treating hematology and oncology diseases. Its primary product, SANGUINATE, facilitates oxygen transfer to deprived cells and tissues, focusing on sickle cell disease comorbidities and anemia-related disorders. Additionally, Prolong offers ANF-Rho, EPEG, PP-403, and other investigational drugs targeting various blood and cancer conditions. The company also provides custom manufacturing services and licenses its products to pharmaceutical companies.

LERETA specializes in providing property tax data and flood hazard status information tailored for the mortgage and insurance industries across the United States. The company offers a technology-driven platform that facilitates regulatory-compliant property tax tracking, payment services, tax department outsourcing, and federally mandated flood zone certifications. By leveraging software-as-a-service (SaaS) technology, LERETA enables clients to enhance workflow management and automate various processes, ultimately improving efficiency and reducing potential penalties and liabilities. With a strong focus on customer service, LERETA's team of dedicated real estate tax and flood professionals, supported by experienced management, positions the company as a leader in service and technological innovation within its sector.

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company that develops, licenses, manufactures, and markets a diverse range of generic and specialty pharmaceutical products. The company operates primarily through two segments: Generics and Specialty. The Generics segment focuses on creating complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across various therapeutic categories. The Specialty segment is dedicated to the development and sale of branded pharmaceutical products, particularly for central nervous system disorders, endocrinology, and parasitic infections. Notable products include Rytary for Parkinson's disease, Zomig for migraines, Emverm for parasitic infections, and Unithroid for hypothyroidism. Amneal Pharmaceuticals distributes its products through wholesalers, distributors, hospitals, and pharmacies, with operations in the United States, India, Ireland, and other international markets. Founded in 2002 and headquartered in Bridgewater, New Jersey, the company was previously known as Atlas Holdings, Inc. before rebranding in 2018.